• October 2011 Core Essence Orthopaedics launches PONTiS™, a novel endotendonous implant for minimally invasive repair of severed tendons
• September 2011 Lerner Medical Devices closes on a $1M Angel financing
• July 2011 Advanced BioHealing Acquired by Shire Pharmaceuticals for $750M
• June 2011 WuXi PharmaTech Named a Top Ten Chinese Outsourcing Enterprise by China’s Ministry of Commerce
• March 2011 Core Essence Orthopaedics receives an $11.3M Series B round led by Baird Venture Partners
• March 2011 WuXi PharmaTech announces collaboration with BMS for a new analytical and stability testing facility
• October 2010 Core Essence Orthopaedics closes on a $2.9M Convertible Debt from Angel Investors
• May 2011 QuantumBio and Chemical Computing Group announce release of DivCon Discovery Suite for MOE
• March 2010 Hygeia Therapeutics closes on a $2.0M round from Angel Investors
• November 2009 Lerner Medical Devices receives 510(k) clearance for Levia® Targeted Phototherapy for Self-Treatment at home
• October 2009 WuXi PharmaTech receives 2009 Schering-Plough Excellence Award
• June 2008 MedAvante closes on a $20M Series A Preferred investment led by Goldman Sachs and Trevi Health Ventures
• December 2007 Lerner Medical Devices closes on a $3.3M Angel Round to develop Levia® device